These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9479425)

  • 1. Attenuation of cryogenic induced brain oedema by arginine vasopressin release inhibitor RU51599.
    Ikeda Y; Teramoto A; Nakagawa Y; Ishibashi Y; Yoshii T
    Acta Neurochir (Wien); 1997; 139(12):1173-9; discussion 1179-80. PubMed ID: 9479425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine vasopressin release inhibitor RU51599 attenuates brain oedema following transient forebrain ischaemia in rats.
    Ikeda Y; Toda S; Kawamoto T; Teramoto A
    Acta Neurochir (Wien); 1997; 139(12):1166-71; discussion 1171-2. PubMed ID: 9479424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of niravoline (RU51599), a kappa-opioid receptor agonist, on tumour-origin brain oedema.
    Takahashi H; Hamada H; Teramoto A
    Acta Neurochir (Wien); 1999; 141(7):771-8. PubMed ID: 10481790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of arginine vasopressin receptor antagonist on the rat cold-injured brain].
    Kagawa M; Nagao S
    No Shinkei Geka; 1993 Dec; 21(12):1103-7. PubMed ID: 8259220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of niravoline, an arginine vasopressin inhibitor, on tumour-origin brain oedema.
    Takahashi H; Hamada H; Teramoto A
    Acta Neurochir Suppl; 2000; 76():323-7. PubMed ID: 11450035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of kappa opioid agonist RU 51599 on osmotic and non-osmotic stimulated arginine vasopressin release and gene regulation in small cell lung carcinoma cells.
    Kim JK; Summer SN; Schrier RW
    Neuropeptides; 1997 Oct; 31(5):423-9. PubMed ID: 9413018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple quantitative evaluation of blood-brain barrier disruption in vasogenic brain edema.
    Ikeda Y; Wang M; Nakazawa S
    Acta Neurochir Suppl (Wien); 1994; 60():119-20. PubMed ID: 7976520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early changes of blood-brain barrier and superoxide scavenging activity in rat cryogenic brain injury.
    Ikeda Y; Toda S; Wang M; Nakazawa S
    Acta Neurochir Suppl (Wien); 1994; 60():136-8. PubMed ID: 7976526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OPC-21268, an orally effective, nonpeptide arginine vasopressin V1 receptor antagonist reduces vasogenic brain edema.
    Bemana I; Takahashi E; Nakamura T; Kuyama H; Nagao S
    Acta Neurochir Suppl; 1997; 70():194-7. PubMed ID: 9416320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa opiate agonist RU 51599 inhibits vasopressin gene expression and osmotically-induced vasopressin secretion in vitro.
    Rossi NF; Kim JK; Summers SN; Schrier RW
    Life Sci; 1997; 61(23):2271-82. PubMed ID: 9408050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of brain edema with a nonpeptide arginine vasopressin V1 receptor antagonist OPC-21268 in rats.
    Bemana I; Nagao S
    Neurosurgery; 1999 Jan; 44(1):148-54; discussion 154-5. PubMed ID: 9894975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine vasopressin receptor antagonists for treatment of vasogenic brain edema: an experimental study.
    Kagawa M; Nagao S; Bemana I
    J Neurotrauma; 1996 May; 13(5):273-9. PubMed ID: 8797177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cold injury-induced brain edema with a nonspecific matrix metalloproteinase inhibitor MMI270 in rats.
    Kawai N; Kawanishi M; Nagao S
    Acta Neurochir Suppl; 2003; 86():291-5. PubMed ID: 14753455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vasopressin on cold-induced brain edema in cats.
    Reeder RF; Nattie EE; North WG
    J Neurosurg; 1986 Jun; 64(6):941-50. PubMed ID: 3701445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of central administration of the kappa-opiate receptor agonist U 69.593 on neurohypophyseal hormone levels in blood and cerebrospinal fluid.
    van Wimersma Greidanus TB; Janssen S; Frankhuijzen-Sierevogel JC; Maigret C; van de Heijning BJ
    Neuropeptides; 1996 Oct; 30(5):452-5. PubMed ID: 8923507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
    Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
    Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of vasogenic brain edema with arginine vasopressin receptor antagonist--an experimental study.
    Nagao S; Kagawa M; Bemana I; Kuniyoshi T; Ogawa T; Honma Y; Kuyama H
    Acta Neurochir Suppl (Wien); 1994; 60():502-4. PubMed ID: 7976630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in centrally released arginine vasopressin by stimulation of the medullary reticular formation].
    Kuniyoshi T
    No To Shinkei; 1992 Jan; 44(1):43-8. PubMed ID: 1562384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of erythropoietin after experimental cold injury-induced vasogenic brain edema in rats.
    Okutan O; Turkoglu OF; Gok HB; Beskonakli E
    Surg Neurol; 2008 Nov; 70(5):498-502. PubMed ID: 18291472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzamil prevents brain water accumulation in hyponatraemic rats.
    Sulyok E; Pál J; Vajda Z; Steier R; Dóczi T
    Acta Neurochir (Wien); 2009 Sep; 151(9):1121-5. PubMed ID: 19415169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.